Form 8-K · Current Report · Filed 2026-07-30
Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance
Altria Group, Inc. reported its financial results for the quarter and first half of 2026, with net revenues of $6.1 billion and $11.5 billion, respectively. The company's adjusted diluted EPS increased by 2.8% to $1.48 for Q2 and by 4.9% to $2.80 for the first half. Altria also narrowed its full-year 2026 guidance for adjusted diluted EPS to a range of $5.61 to $5.72, representing a growth rate of 3.5% to 5.5% from a base of $5.42 in 2025. The company repurchased shares and paid dividends, and provided updates on its smoke-free portfolio and segment performance.
- Filer
- Altria Group, Inc. MO · NYSE
- Filed
- Accession
- 0000764180-26-000093
- CIK
- 0000764180
- Signal
- High impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$74.92
Next session
-8.8%
Since filing
-8.8%
Latest close
$68.33
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MO reporting the same item, with the next session's move:
About Altria Group, Inc.
Altria Group, Inc. is a holding company with a primary focus on the manufacture and sale of cigarettes and related products. Serving as a leading player in the tobacco industry, Altria is best known for its premium cigarette brand, Marlboro, which holds a significant market share in the United States. Beyond cigarettes, the company has established a diversified portfolio by investing in smokeless tobacco products, wine via its subsidiary Ste. Michelle Wine Estates, and a stake in the cannabis market through its investment in Cronos Group. Altria's strategic expansions into non-cigarette categories reflect its aim to navigate changing consumer preferences and regulatory landscapes. As one of the foremost publicly traded entities in its sector, Altria plays a significant role in the broader consumer goods market. The company continues to engage with shifting market dynamics by fostering innovation in reduced-risk products while maintaining its strong presence in traditional tobacco markets.
Never miss another MO filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.